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Termini restraining of small membrane
proteins enables structure determination at
near-atomic resolution
Shixuan Liu, Shuang Li, Yihu Yang, Weikai Li*

INTRODUCTION

Integral membrane proteins constitute approximately 30% of proteomes in prokaryotes and eukaryotes, and they represent more
than half of the drug targets. Elucidating their molecular functions
and facilitating the development of new drugs requires knowledge
of their three-dimensional structures. Structural studies generally
start from protein overexpression in cells, followed by protein purification from the native membranes with selected detergents.
These operations frequently disrupt the function and folding of
membrane proteins, resulting in their denaturation and aggregation (Fig. 1). To overcome this difficulty, structural biologists often
perform large screens of homologous proteins to identify a few that
show sufficient stability during overexpression and purification (1).
Most membrane proteins, however, need to have their instability
and flexibility reduced before they can be structurally characterized.
One approach to enhance protein thermostability is systematic mutagenesis of the entire protein to identify multiple synergistically
stabilizing mutations, a trial-and-error method that requires tedious effort (2–4). Another time-consuming and costly approach is
the search of suitable antibodies that can stabilize a flexible region
of membrane proteins and provide a scaffold for cocrystallization (5)
or cryo–electron microscopy (cryo-EM) analyses (6). Structure
determination of heterotrimeric GTP-binding protein (G protein)–
coupled receptors (GPCRs) can be accomplished by replacing an
intracellular loop in GPCRs with a highly crystallizable soluble protein
(7, 8). However, there are limited reports of applying this engineering
method to obtain structures of membrane proteins from other families,
because it is unknown which flexible loops should be replaced, and
the replacement is restricted by the size of the soluble protein.
Moreover, lessons learned from GPCRs are that their G protein
coupling function is compromised by the replacement of the intracellular loop (7), by an antibody bound to this functionally essential
loop (9), and even by heterologous overexpression in insect cells
Department of Biochemistry and Molecular Biophysics, Washington University
School of Medicine, St. Louis, MO 63110, USA.
*Corresponding author. Email: weikai@wustl.edu
Liu et al., Sci. Adv. 2020; 6 : eabe3717

18 December 2020

(10). Together, maintaining the native structure and function of
membrane proteins in vitro remains the biggest hurdle to overcome
for structural biologists (11).
Structure determination of small membrane proteins poses additional challenges. More than 60% of membrane proteins have fewer
than the seven transmembrane helices (TMs) that GPCRs have (12).
These small proteins are difficult targets for crystallography. With
their membrane portion buried in the detergent micelles, these proteins are often left with either small exposed regions that can barely
provide crystal contacts or large flexible loops that may destabilize
crystal contacts (Fig. 1). Because many of these proteins are not subunits of a large and stable assembly, their small size generally places
them beyond the reach of cryo-EM techniques, which are currently
striving toward a minimum size of ~100 kDa for membrane proteins.
As a result, small membrane proteins are much underexplored by
structural biology. Taking the example of four-TM proteins, structures have been reported so far for only six individual proteins—
CD81 (13), CD9 (14), Cldn4 (15), Cldn9 (16), DHHC20 (17), and
SCD1 (18)—from hundreds of these in the human genome (19). To
meet this critical challenge, here, we develop a termini-restraining
approach to facilitate the entire structure determination process of
small membrane proteins. This new approach gives rise to 14 structures of five proteins from humans and other vertebrates, whose
structures were unknown from traditional approaches, and a high-
resolution structure of bacterial disulfide bond formation protein B
(DsbB) that reveals its catalytic chemistry, thereby bringing a substantial expansion to the current structural database of small membrane proteins.
RESULTS

Design principles of termini restraining
Our strategy is to stabilize small membrane proteins by restraining
their two termini with a coupler formed of two associable protein
entities (Fig. 1). As a proof of concept, we fused the N and C termini
of the membrane proteins to the N- and C-terminal halves of a
superfolder green fluorescent protein (sfGFP), respectively; split
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Small membrane proteins are difficult targets for structural characterization. Here, we stabilize their folding by
restraining their amino and carboxyl termini with associable protein entities, exemplified by the two halves of a
superfolder GFP. The termini-restrained proteins are functional and show improved stability during overexpression
and purification. The reassembled GFP provides a versatile scaffold for membrane protein crystallization, enables
diffraction to atomic resolution, and facilitates crystal identification, phase determination, and density modification.
This strategy gives rise to 14 new structures of five vertebrate proteins from distinct functional families, bringing
a substantial expansion to the structural database of small membrane proteins. Moreover, a high-resolution structure
of bacterial DsbB reveals that this thiol oxidoreductase is activated through a catalytic triad, similar to cysteine
proteases. Overall, termini restraining proves exceptionally effective for stabilization and structure determination
of small membrane proteins.
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Fig. 1. Termini restraining of small membrane proteins facilitates their entire
structure determination process. (Left) Difficulties with traditional structural biology approaches (blue box). (I) Overexpression of membrane proteins increases
their tendency to unfold and aggregate in cells. The unfolding involves large relative motions between TMs (dashed arrow). (II) Protein purification in detergents is
often disruptive to the native folded state of membrane proteins. (III) Small membrane proteins in detergent micelles often contain either small exposed regions or
large flexible loops, both of which increase the difficulty of making crystal contact.
These proteins are also too small for structural determination by cryo-EM. (Right)
Termini-restraining strategy (orange box). (I′) Two associable protein entities (coupler; green) are fused to the flexible N and C termini of a membrane protein (blue),
providing a loose restraint to stabilize its folded state during protein overexpression
in cells (I′) and protein purification in detergents (II′). (III′) Introducing the coupler
protein also provides a large surface for crystal packing and facilitates structure
determination.

sfGFP has been optimized for efficient self-association in previous
works (20, 21). Tethering this soluble coupler protein to the two
flexible termini of the membrane proteins provides a mild restraint,
hampering the drastic TM motions that lead to unfolding and thus
favoring their folded state during protein overexpression and purification. The flexible portions of the two termini loosely connect the
coupler to the first and last TMs of membrane proteins, permitting
moderate conformational changes that are usually sufficient for
the normal protein function. This approach requires that the two
termini of the target proteins are located on the same side of the
membrane. Given that most membrane proteins are predicted to
have even numbers of TMs and to have both termini in the cytosol
(22, 23), this engineering strategy can be applied to numerous
membrane proteins with such folding topology.
Liu et al., Sci. Adv. 2020; 6 : eabe3717
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Retained protein functions after termini restraining
Our first priority was to confirm that termini restraining does not
compromise protein functions. The restrained VKOR and VKORL
retain their cellular reductase activity and became slightly more
sensitive to the inhibition by warfarin, an anticoagulant targeting
these enzymes (Fig. 2A). A historically challenging example of protein
instability, human VKOR rapidly loses enzymatic activity during
purification; this prevented the biochemical identification of this
protein before the genomic era (31). With the two termini restrained,
purified human VKOR shows a specific activity 20 times higher than
the unrestrained protein does (Fig. 2B), suggesting that the restraining
markedly increases protein stability. Similarly, the specific activity
of the restrained VKORL is five times higher than that of the wildtype VKORL (Fig. 2B). The restrained DsbB, like the wild-type DsbB,
can promote disulfide bond formation in Escherichia coli; both constructs complement the motility defect of a ∆dsbB strain (32) and
inactivate a disulfide-sensitive -galactosidase fusion protein (Fig. 2C)
(33). Cldn4, another protein that we could assay for function, retains interactions of forming high-order complexes at the cell junction
after the sfGFP restraining (Fig. 2D). In particular, the restrained
Mfrn1, which needs to transport iron via large rocking motions
(34), exhibits high activity in liposomes as the unrestrained Mfrn1
does (Fig. 2E). Together, these examples indicate that termini restraining maintains the transport activity, enzymatic activity, and
molecular interaction of these representative membrane proteins,
even when large conformational changes are required for their
functions.
Protein stability during overexpression and purification
Because overexpression often causes misfolding or aggregation of
membrane proteins (10, 35), we compared the sfGFP-restrained
proteins with those tagged with a C-terminal GFP (C-GFP). Fluorescence imaging showed that termini restraining does not change
the subcellular localization of these proteins (Fig. 2F and fig. S1).
Moreover, the reconstituted fluorescence of sfGFP indicates that
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Downloaded from http://advances.sciencemag.org/ on January 11, 2021

Detergent
micelle

Selection of small membrane proteins
To test the generality of our approach, we selected seven model
proteins from humans or other vertebrates (Table 1) that were considered difficult structural targets. These small membrane proteins
(10 to 40 kDa) contain even numbers of TMs (2, 4, 6), but their
three-d imensional structures were unknown. These proteins
represent distinct functional families, including membrane enzymes,
adhesion molecules, and transporters. Vitamin K epoxide reductase
(VKOR) and VKOR-like (VKORL) are thiol oxidoreductases. Signal
peptidase complex subunit 1 (SPCS1) is a serine protease subunit
required for the processing of flaviviral proteins (24). CD53 is a member of the tetraspanins (25). Claudin 4 (Cldn4) forms the backbone
of tight junction (15). Jagunal homolog 1 (JAGN1) is involved in
vesicle-mediated transport (26). Mitoferrin-1 (Mfrn1) belongs to the
SLC25 carrier family that transports solutes across the mitochondria inner membrane (27). We have also included DsbB, a bacterial
oxidoreductase that has been previously cocrystallized with its partner
protein (DsbA) or in the presence of an antibody (28, 29), but these
tremendous measures produced structures of only moderate resolution (3.4 to 3.7 Ǻ) that lack protein side-chain information (30).
Thus, DsbB serves as a benchmark that allows us to compare the
result of structure determination by traditional methods and by our
termini-r estraining approach.
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Table 1. Summary of small membrane proteins, enhancement of protein stability after termini restraining, and improvement of structural resolution
after termini shortening. ER, endoplasmic reticulum; MW, molecular weight; Tm, melting temperature; TR, termini restraining; N/A, not analyzed or not
available; War, warfarin; n.p., autobuilding not performed because of poor data quality; PDB, Protein Data Bank.
Protein

SPCS1

VKOR*

VKORL*

DsbB

JAGN1

CD53 (43)

Cldn4

Mfrn1

Gallus gallus

Homo sapiens

Takifugu rubripes

Escherichia coli

Homo sapiens

Homo
sapiens

Homo
sapiens

Oreochromis
niloticus

Protein function or
family
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peptidase
subunit

Thiol
oxidoreductase

Thiol
oxidoreductase

Thiol
oxidoreductase

Vesicle
transport

Tetraspanin

Claudin

Mitochondrial
transporter

Subcellular
location

ER
membrane

ER membrane

ER membrane

Cytoplasmic
membrane

ER membrane

Cytoplasmic
membrane

Cytoplasmic
membrane

Mitochondria
inner
membrane

Origin

TM no.

4

4

4

4

4

4

6

11.6

18.2

19.6

20.1

21.1

24.3

22.1

36.7

Length (amino
acids)

101

163

175

176

183

219

209

338

Folded protein†

+

++

+++

+/−

+++

−

+/−

++

Tm before TR (°C)

64.6

49.2

53.3

49.5

57.8

79.7

85.2

58.9

Tm after TR (°C)

64.4

52.1

62.1

>90

66.3

80.2

73.0

60.2

N/A

Improved
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N/A

N/A
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Maintained

Initial (amino
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Full length
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Full length

Full length
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N/A

  Resolution (Å)

~5

5.7

4.3

3.7

2.25

2.9

N/A

N/A

C222

P222
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P2

C2

P2

   a, b, c (Å)

69.8, 366.7,
44.4

65.2, 89.2, 96.2

88.5, 88.5, 335.6

83.5, 56.5, 120.3

90.8, 42.7,
111.8

49.4, 210.5,
73.4

   , ,  (°)

Protein stability

Activity or
function
Crystallization

   Space group
  Cell dimensions

90, 90, 90

90, 90, 90

90, 90, 90

90, 96.5, 90

90, 103.8, 90

90, 100.2, 90

  Solvent content

69.2%

59.3%

65.5%

62.3%

67.0%

45.6%

  Phase
improvement

Solvent
flattening

Solvent
flattening

Cross-crystal

Solvent
flattening

Solvent
flattening

Twofold
averaging

n.p.

n.p.

57.9%

n.p.

93.4%

96.4%

Shortened
(amino acids)

1–75

3–155 (War)

6–175

6–167

N/A

N/A

N/A

N/A

  Resolution (Å)

2.45

2.2

2.4

2.9

  Space group

C2

P21212

C2

P3221

   a, b, c (Å)

105.0, 55.3,
92.7

47.4, 70.9, 153.1

153.6, 49.1, 84.3

53.4, 53.4, 280.7

   , ,  (°)

90, 110.9, 90

90, 90, 90

90, 112.7, 90

90, 90, 120

19.5/22.7

22.3/26.5

N/A

N/A

  Auto
building§

  Cell dimensions

  Solvent content

65.2%

57.8%

60.8%

52.2%
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Solvent
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Solvent
flattening

Solvent
flattening

Cross-crystal

  Auto
building§

90.5%

84.3%

97.8%

83.1%

Rwork/Rfree (%)

20.4/23.2

20.1/22.3

20.5/23.7

26.0/28.6
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Protein
PDB code

SPCS1

VKOR*

VKORL*

DsbB

JAGN1

CD53 (43)

Cldn4

Mfrn1

6WVE

6WV3, 6WV6,
6WVH, 6WV4,
6WV5, 6WV7

6WVI, 6WVB,
6WV8, 6WV9,
6WVA

6WVF

6WVD

6WVG

N/A

N/A

*Biological interpretations of the VKOR and VKORL structures are being reported in an accompanying manuscript (42).   †Changes in the fraction of folded
membrane proteins after TR are roughly estimated (+ or − signs) from the whole-cell extraction of overexpressed proteins with SDS, SDS/urea, and
DDM.   ‡This construct was used according to Inaba et al. (28).   §Autobuilding was performed with BUCCANEER using the density modification maps
generated from PARROT (see Materials and Methods).
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Crystallization and structure determination
Seven restrained membrane proteins—VKOR, VKORL, CD53, SPCS1,
Cldn4, JAGN1, and DsbB—could be readily crystallized in lipidic-
cubic phase (LCP) (Table 1). We optimized all the crystals except
Cldn4, whose structure was reported during our study (15). The
effort of optimization was immediately justified, because the sfGFP
coupler can be detected under fluorescence microscope. Even tiny
protein crystals can be distinguished from other particles made of
salt, detergent, or lipids (Fig. 3A). Traditionally, it requires months
of effort to optimize the initial hits and allow crystals to grow large
enough to confirm the presence of the target protein by crystal diffraction pattern or by silver staining of dissolved crystals. The sfGFP
coupler bypasses this technical bottleneck.
The sfGFP coupler affords a highly versatile scaffold for the
crystallization of small membrane proteins, which have different
sizes, shapes, and surface properties (Fig. 3B and fig. S2A). Each of
the sfGFP-restrained proteins crystallized in a different space group
or with different unit cell dimensions (Table 1, table S1, Fig. 3C, and
fig. S2B). Even for the same protein, VKOR or VKORL, alternative
reactive states or different bound ligands generated five and three
different crystal forms, respectively (table S2 and fig. S2C). Despite
these differences, the crystal lattices are always packed into two alternative layers, one made by sfGFP molecules and another by the
small membrane proteins (Fig. 3C and fig. S2, B and C). Crystal
contacts can also be formed between the TM regions of the membrane protein molecules, likely induced by the LCP crystallization
condition. To accommodate the different membrane proteins, sfGFP
molecules form various lattice packing interactions using nearly
every part of its large polar surface (Fig. 3D). None of the 12 crystal
forms exhibits the same packing pattern in the layer of sfGFP molecules (fig. S2, B and C). This remarkable adaptability shows that
termini restraining by sfGFP is broadly applicable to crystallizing
small membrane proteins.
The quality of crystal diffraction is markedly improved by shortening the flexible termini regions of membrane proteins tethered to
sfGFP. This shortening induced alternative crystal packing. For instance, crystals of the restrained full-length VKORL only diffracted to
4.3 Å (Fig. 4A). Shortening the N terminus of VKORL by a mere five
amino acids changed the space group from P43212 to C2 (Table 1)
with completely different crystal packing interactions (Fig. 4B), probably by restricting the relative motion between sfGFP and VKORL
molecules. As a result, the remaining part of the VKORL N terminus
becomes ordered in the C2 crystal form, and the orientation of
VKORL with respect to sfGFP becomes different (Fig. 4C). The
solvent content decreases by 5%, and the crystal diffraction improves to 2.4 Å (Fig. 4A). Similar termini optimizations changed the
crystal packing of VKOR, DsbB, and SPCS1 (Table 1) and markedly
4 of 12
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proteins with even numbers of TMs fold properly in their predicted
topologies (36). Some of the C-GFP–tagged proteins, such as VKORL,
appear to accumulate in the endoplasmic reticulum (ER) and/or
vacuoles, whereas the sfGFP-restrained proteins are distributed
evenly at the ER membrane boundary. To understand this difference,
we compared the whole-cell extraction of the restrained and unrestrained proteins in the presence of SDS, SDS/urea, and n-dodecyl-D-maltoside (DDM) detergents, the latter of which preferably
solubilizes correctly folded membrane proteins (10). For C-GFP–tagged
VKOR, VKORL, JAGN1, SPCS1, and Mfrn1, the amount of DDM-
extractable protein was much less than that extractable by SDS
and/or SDS/urea, indicating that a large portion of these recombinant
proteins are expressed in aggregated or insoluble form (Fig. 2G). In
contrast, termini restraining substantially increases the DDM-extractable
fraction of these ER and mitochondrial proteins, indicating that the
restraining can prevent protein aggregation during overexpression.
The relative level of DDM-extractable protein, however, is similar for
the restrained and unrestrained DsbB from E. coli cytoplasmic membrane. For the human proteins located on the cytoplasmic membrane,
we found that the DDM-extractable fraction remains nearly unchanged
for restrained Cldn4 and becomes less for restrained CD53, probably
because these cell surface proteins are intrinsically stable and therefore
their stability is not improved by termini restraining. Overall, although
we did not observe improvement for every protein, the restraining
affords a readily testable approach to increase the effective production of membrane proteins, presumably through stabilizing their
folded state in cells.
The ability of proteins to maintain their folded state usually
correlates with their thermostability (37). Therefore, we measured
the melting temperature (Tm) of proteins purified in detergent
solution by using fluorescence-detected size exclusion chromatography (FSEC), a well-established assay for membrane protein stability
(38). To allow precise comparison, we tagged the sfGFP-restrained
and unrestrained constructs with a C-terminal mCherry for FSEC
detection. This design avoids the Tm comparison between split and
integral GFPs; instead, the sfGFP serves only as the coupler, and the
Tm is measured through the change of mCherry signal. The restraining raised the Tm by 8.8°C for VKORL and 8.5°C for JAGN1
(Fig. 2H). The Tm change of DsbB after restraining is even more
substantial, from 50°C to more than 90°C. The comparison of
VKOR proteins required further stabilization with bound warfarin,
under which condition the restraining increased the Tm by 2.9°C.
The restraining slightly changes the Tm of SPCS1, CD53, and
Mfrn1, and lowers that of Cldn4, probably because the unstrained
Cldn4 has an inherently high Tm (85°C). This restraining approach
thus appears to be more effective at improving the detergent stability of proteins with relatively low Tm.
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Fig. 2. Termini restraining maintains the functions of small membrane proteins and enhances their stability during overexpression and purification. (A) Cellular
activities of termini-restrained (TR) and unrestrained constructs of VKOR and VKORL in response to warfarin inhibition. (B) Activities of purified VKOR and VKORL constructs at the same protein concentration. (C) DsbB-catalyzed disulfide bond formation. Left: Transformations restore the motility (measured by colony size) of ∆dsbB
E. coli. EV, empty vector. Right: Disulfide-mediated inactivation (white colonies) of MalF-fused -galactosidase. (D) Cldn4-mediated cell junction. Fluorescence images are
of live human embryonic kidney (HEK) 293 cells transfected with Cldn4 constructs. (E) Fe2+ uptake activity of purified Mfrn1 in liposomes (50). Cal, calcimycin. See Materials
and Methods for explanation of assays in (A) to (E). (F) Fluorescence images of live Pichia cells overexpressing ER membrane proteins with C-GFP tag or sfGFP restraining.
The merged images combine GFP fluorescence with ER marker. Red arrows indicate potential protein accumulation in the ER and/or vacuoles. DIC, differential interference
contrast. (G) Comparison of extractable folded membrane protein fraction with or without the termini restraining. The immunoblots are shown for target proteins extracted
from whole cells with SDS, SDS/urea, or DDM. (H) FSEC-based thermostability assay of purified proteins showing change of Tm (Tm) with termini restraining. The
unrestrained (U) and sfGFP-restrained constructs both carry a C-terminal mCherry tag for fluorescence detection.
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Fig. 3. The sfGFP coupler enables crystallization of small membrane proteins.
VKORL and SPCS1 are shown as examples here; other proteins are shown in fig. S2.
(A) Identification of initial crystallization hits (left) of sfGFP-restrained VKORL
through fluorescence imaging. The optimized crystals (right) are shown for comparison.
(B) Electrostatic surfaces of VKORL and SPCS1 showing their different shapes and
surface charges (blue, positive charge; red, negative charge). (C) sfGFP serves as a
crystal packing scaffold that is highly adaptable to accommodate various small
membrane proteins. Each crystal is packed with alternative layers (dashed lines) of
sfGFP (green) and small membrane protein (SMP) molecules. The TMs (numbered)
are shown in blue, and extramembrane regions are shown in red. Different membrane protein molecules in the crystals are indicated (A and B). (D) Zoom-in view of
versatile crystal packing interactions formed among sfGFP molecules. The large
polar surface of sfGFP can accommodate a multitude of crystal contacts (purple
surface). The  strands in sfGFP are numbered to illustrate location of the contacts.

improved their crystal diffractions to near-atomic resolution
(up to 2.0 Ǻ).
The crystallographic phase problem was solved using the structural
model and diffraction data of the sfGFP coupler. Molecular replacement (MR) with the sfGFP model [Protein Data Bank (PDB) code
2B3P] readily generated solutions for all datasets, because the membrane proteins are small and sfGFP constitutes a relatively large portion
of the diffraction mass. For the high-resolution datasets, after rigid
body refinement of the MR model and solvent flattening with automatically generated mask, the electron density maps (figs. S3 and S4),
which are unbiased at the membrane protein region, allowed automatic model building for a major part (often above 90%) of the target
proteins (Table 1). Even at low resolution, the initial MR phases could
Liu et al., Sci. Adv. 2020; 6 : eabe3717
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Maintained DsbB structure after termini restraining
The overall structure of termini-restrained DsbB (Fig. 5A) closely
matches previously determined structures of DsbB, indicating that
the restraining does not disrupt the protein conformation. The
transmembrane region of restrained DsbB has a root mean square
deviation (RMSD) of 1.1 Å to that of 2ZUQ (Fig. 5B) (29). The short
-hairpin that folds on top of TM4 is also maintained. The conformation of a long loop connecting TM3 and TM4 is similar to the
nuclear magnetic resonance (NMR) structure of a Cys44Ser/Cys104Ser
mutant (44) because of formation of the same interloop disulfide,
Cys130-Cys41 (Fig. 5C). This interloop disulfide is induced by a
Cys104Ser mutation, which also allows a charge-transfer complex to
form between Cys44 and the quinone cofactor of DsbB in our structure (fig. S7).
DsbB activation by a catalytic triad
The high-resolution structure reveals that thiolate activation in
E. coli DsbB uses a catalytic triad that is reminiscent of the classical
mechanisms used by cysteine or serine proteases (Fig. 5D). The
electron density maps clearly show the protein side chains and the
quinone ring at the active site (fig. S5C). The quinone ring is stacked
between Arg48 at the bottom and Cys44 and Met142 on the top. Cys44,
His91, and Glu47 form the catalytic triad, whose spatial arrangement
is essentially the same as that observed in the cysteine proteases
(Fig. 5D) (45, 46). Thus, a similar mechanism may be used by the
thiol oxidoreductase DsbB to activate Cys44 (Fig. 5E). This process
starts from the deprotonation of His91, probably with assistance
from Glu47. Next, His91 abstracts the proton from the sulfhydryl
group of Cys44, generating a nucleophile to attack the quinone. The
negative charge of Cys44 thiolate is not stabilized by Arg48 (29) because it is on the other side of the quinone ring. Instead, Arg48 may
6 of 12
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be markedly improved by cross-crystal averaging (39) with the diffraction data of sfGFP alone (Fig. 4D). For instance, averaging the
sfGFP data with the 4.3-Å VKORL data [twofold noncrystallographic
symmetry (NCS)] generates a well-featured electron density map
(Fig. 4E) that allowed correct building of nearly all TMs (Fig. 4F). The
same cross-crystal averaging approach is also useful for data at higher
resolution and without NCS, such as the 2.9-Å data of DsbB (fig. S5).
Overall, model phasing with the sfGFP coupler avoids experimental
phasing, a tedious and sometimes unsuccessful process.
The termini-restraining approach yields the first structures of five
small membrane proteins from humans and other vertebrates (Fig. 5A).
The structures of VKOR and VKORL, unlike their bacterial homolog
structures (fig. S6) (40, 41), elucidate almost their entire catalytic cycle
and their mechanism of inhibition by warfarin and other antagonists,
which are oral anticoagulants commonly used to treat and prevent
thromboembolic diseases such as stroke and heart attack (42). The
crystal structure of CD53 is the first structure ever captured of the
partner-interacting state for the entire tetraspanin family (43), which
mediates molecular interactions for myriad cellular processes (25).
SPCS1 is a major therapeutic target of Zika virus (24), and its structure suggests a regulatory role for this signal peptidase subunit during
the maturation process of Zika and other flaviviruses. Last, the
JAGN1 structure reveals a unique structural fold that may allow
specific interaction with proteins involved in vesicle-mediated transport. Thorough analyses of these new structures are being reported
elsewhere (42, 43); here, we focus on the benchmark example, DsbB,
a disulfide bond formation enzyme.
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VKORL. Diffraction patterns are shown for full-length (left) and termini-shortened (right) VKORL restrained by sfGFP. Arrows indicate visible diffraction spots near the
diffraction limit. (B) Change of crystal packing interactions. The coloring and annotations are the same as in Fig. 3C. (C) Change of relative orientation between the membrane
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flattening. All the maps are contoured at 1.

stabilize the entire charge-transfer complex and also facilitate its
formation through inducing polarization of the quinone ring. Consistent with this mechanism, Arg48 and His91 are two of the most
conserved residues in DsbB homologs (47). Moreover, mutations of
Arg48, His91, and Glu47 show accumulation of DsbB-DsbA complex
and/or reduced quinone binding (47, 48), both of which may result
from impaired Cys44 reactivity. The quinone reduction activity of
His91Ala and Glu47Ala mutants is also drastically reduced (fig. S8).
Together, these new insights gained from our termini-restraining
approach offer a much clearer picture of the redox chemistry of
E. coli DsbB.
Liu et al., Sci. Adv. 2020; 6 : eabe3717
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DISCUSSION

With termini restraining, structural determination of small membrane proteins at near- atomic resolution becomes relatively routine. We
have obtained a total of 15 crystal structures of six different proteins
(42, 43), three of which are of human origin and two from other
vertebrates (Table 1 and Fig. 5A). Obtaining the structure of an individual 2-TM protein (SPCS1) by crystallography is, to our knowledge, unprecedented; the 2-TM proteins alone constitute ~10% of
the membrane proteome (12). Without the sfGFP coupler, SPCS1
and JAGN1 only contain small exposed loops, whereas VKOR,
VKORL, DsbB, and CD53 have large and flexible extramembrane
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regions, making them difficult targets for traditional membrane
crystallography. Unlike any other approach, termini restraining now
affords an effective way to crystallize these proteins.
The underlying principle of termini restraining is fundamentally
different from conventional protein engineering methods used in
structural biology. The termini restraining affords a global stabilization
by inserting the entire membrane protein into a highly stable coupler protein, thereby enhancing the overall stability of the restrained
constructs. Unlike systematic mutagenesis (2–4), the restraining is a
rational way of stabilizing overall membrane protein fold (Fig. 1)
and requires minimal construct screening. An effective mutation
(2) generally increases the Tm by 1° to 3°C, whereas the restraining
increases the Tm of DsbB by more than 40°C and the Tm of two
other proteins by 8° to 9°C. Increased protein thermostability should
Liu et al., Sci. Adv. 2020; 6 : eabe3717
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limit the frequency of transiently unfolded states, thereby lowering the probability of protein aggregation in the cellular environment and in vitro (37). Several restrained proteins show much less
aggregation during overexpression (Fig. 2G). Consequently, we obtained much higher yield of functional proteins after purification,
some with increased specific activity (Fig. 2B).
This restraining strategy requires only that the two protein termini are located at the same side of the membrane, and therefore, it
is nearly universally useful for proteins with even numbers of TMs
from any protein family (Table 1). The varying distances between
the ends of N- and C-terminal TMs of different proteins do not
affect the ability of termini restraining to stabilize and crystallize
these proteins (Fig. 5A). Furthermore, termini restraining does not
change the integrity of the target membrane protein by replacing an
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MATERIALS AND METHODS

Constructs and cloning
Termini restraining was performed by fusing sfGFP residues 1 to
144 and 146 to end (20) to the N and C termini of target membrane
proteins (Table 1), respectively. The constructs used for functional
assays, fluorescence imaging, whole-cell extraction, and crystallization have a 10× His tag or FLAG tag added to the C terminus of
truncated sfGFP (1 to 230). For Tm measurements, the constructs
are fused into a full-length sfGFP, followed by a PreScission protease
cleavage site, mCherry, and 10× His tag. The unrestrained constructs
were generated by tagging the membrane proteins with the PreScission
site, enhanced GFP (EGFP; or mCherry), and 10× His tag or FLAG
tag. The unrestrained VKOR and Mfrn1 required the addition of an
N-terminal small ubiquitin-like modifier protein (SUMO) tag to
improve their expression level in Pichia pastoris (50). To be consistent,
the restrained VKOR and Mfrn1 used for the Tm measurements also
contain the N-SUMO tag. The coding sequences of these constructs
were cloned into a modified pPICZ-A vector for expression in P. pastoris
Liu et al., Sci. Adv. 2020; 6 : eabe3717
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and a pBudCE4.1 vector for expression in HEK293 cells. DsbB
constructs were cloned into pET28b for FSEC-Tm analysis and crystallization and cloned into pET25b for activity assays. Termini truncations and mutations of the crystallization constructs were performed
by one-step site-directed mutagenesis (51).
Protein expression
For protein expression in P. pastoris, plasmids were linearized and
transformed into the Pichia cells by electroporation. Clones with the
highest expression level were selected by FSEC (38). The cells were
grown at 30°C for 20 hours in the buffered minimal glycerol (BMG)
media [1.2% glycerol, 0.34% yeast nitrogen base, 1% ammonium sulfate,
biotin (0.4 g/ml), and 100 mM potassium phosphate (pH 6.0)].
After exchanging to the buffered minimal methanol (BMM) media
(0.34% yeast nitrogen base, 1% ammonium sulfate, biotin (0.4 g/ml),
and 200 mM potassium phosphate (pH 6.0)], the cells were induced
with 0.7% methanol and grown for 1 to 3 days at 25°C. The harvested
cells were flash-frozen in liquid nitrogen.
The DsbB-containing plasmids were transformed to E. coli C41 cells.
The cells were grown in LB medium at 37°C to 0.6 optical density (OD).
Subsequently, the cells were induced with 0.4 mM isopropyl--d-
thiogalactopyranoside (IPTG) and grown at 25°C overnight. The harvested
cells were used immediately for protein purification and other assays.
Expression of CD53, Cldn4, and Mfrn1 in HEK293 cells was through
transient transfection of 0.6 g of plasmids with Lipofectamine 3000.
The cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)
with 10% fetal bovine serum at 37°C for 2 days.
Cell imaging
Live Pichia and HEK293 cells were stained with different dyes according
to the expected subcellular location of different membrane proteins.
ER-Tracker Blue-White DPX (5 M) was used for the ER membrane,
FM 4-64 (10 g/ml) was used for the plasma membrane, and
MitoTracker Red (10 g/ml) was used for the mitochondria. The
excitation/emission wavelengths were 405/430 nm for ER-Tracker,
561/575 nm for FM4-64 and MitoTracker, and 488/561 nm for sfGFP
or EGFP fused to membrane proteins. The live cells were viewed under
a Zeiss LSM 880 II Airyscan FAST confocal microscope with 63× oil immersion objective for Pichia cells and 40× oil objective for HEK293 cells.
Whole-cell fractionation
Frozen Pichia cells were disrupted with a mixer mill (Retsch) to break
the cell wall. The cells were resuspended in tris-buffered saline (TBS)
buffer [0.15 M NaCl and 20 mM tris-HCl (pH 8.0)], and cell membranes were lysed via microfluidization. The same amount of the
whole-cell suspension was extracted in 2% DDM, 2% SDS, or a mixture of 2% SDS and 6 M urea (adjusted to the same final volume using
TBS buffer with protease inhibitors) at room temperature for 30 min.
After ultracentrifugation at 88,760g, the supernatant was heated in the
SDS sample buffer [with 40 mM dithiothreitol (DTT)] at 90°C for
10 min and loaded onto SDS–polyacrylamide gel electrophoresis. The
Western blots used the His tag antibody (GenScript, A00186) for
most proteins. For human VKOR, anti-VKORC1 antibody (Thermo
Fisher Scientific, PA560093) was used.
CD53, Cldn4, and Mfrn1 were expressed in HEK293 cells because the Pichia expression of these proteins results in incorrect
subcellular locations even for the C-GFP–tagged constructs. The
cells were resuspended in TBS buffer and extracted in 2% DDM,
0.1% SDS/1% Triton X-100, or a mixture of 0.1% SDS/1% Triton
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essential structural component. As a result, the biological functions
are retained for the various membrane proteins that we have analyzed (Fig. 2, A to E). In particular, the example of Mfrn1 suggests
that the termini restraining is applicable to many classes of transporter proteins by permitting the large rocking motions required
for their activities. Furthermore, formation of high-order complex,
such as the cell junction (extracellular side) mediated by Cldn4
(Fig. 2D), may not be interfered by termini restraining at the other
side of the membrane (intracellular side). Cautions should be taken,
however, in that the fused coupler protein may interfere with protein complex formation or other protein functions at the same side
of the membrane where the coupler protein is introduced.
The termini restraining affords a combined strategy to obtain
near-atomic-resolution structures, which are often essential to mechanistic understandings of protein function, as with the redox chemistry
of DsbB that we report here. These well-diffracting crystals only
form in the presence of the coupler protein, sfGFP, which affords a
large and versatile polar interface for stable packing interactions
(Fig. 3, B to D, and fig. S2, B and C) and also increases the relative
diffraction mass. The restrained constructs are compatible with the
LCP crystallization method (49) that further improves the structural
resolution. Linking both termini of the membrane protein to sfGFP
reduces their relative motions, and optimizing the termini length
effectively improves crystal diffraction (Fig. 4 and Table 1). The sfGFP
also enables crystal identification, phase determination, and density
modification (Figs. 3A and 4D). Together, introducing the sfGFP
coupler facilitates the entire pipeline of obtaining high-resolution
crystal structures of small membrane proteins.
Our method is currently limited to small membrane proteins with
even numbers of TMs but is potentially applicable to those with odd
numbers of TMs by fusing one component of the associable protein
entities to an internal loop. The restraining can be extended to use
other self-associable entities, such as protein domains, protein oligomers, or complexes, or to use intein-mediated polypeptide joining.
This strategy is not limited to structural studies, as the idea of termini
restraining may inspire future developments of protein engineering
and protein design. Moreover, functional membrane proteins with improved stability and increased yield enable their biochemical and biophysical studies and fulfil many drug discovery and therapeutic needs.
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X-100 and 6 M urea at room temperature for 30 min. After ultracentrifugation, the fractionated samples were subjected to Western
blot using anti-FLAG antibody (Sigma-Aldrich, F2555).

Thermostability FSEC
The peak fractions from size exclusion chromatography were pooled,
and the protein concentrations of restrained and unrestrained proteins were adjusted to a similar level (usually 1 mg/ml). The restrained and unrestrained pairs were simultaneously incubated at
different temperatures (in a thermocycler) for 10 min. After centrifugation at 20,000g for 1 hour, the supernatant was analyzed by
Liu et al., Sci. Adv. 2020; 6 : eabe3717
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Functional assays
The cellular carboxylation assay of VKOR and VKORL activities
was performed as previously described (53, 54). Briefly, VKORL and
VKORL clones, along with a luciferase gene, in a pBudCE4.1 vector
were transfected into a cell line that contains a chimeric factor IX
Gla and protein C (FIXgla-PC) gene and has endogenous VKORC1
and VKORL1 genes knocked out. The carboxylation level of secreted
FIXgla-PC was measured by a sandwich enzyme-linked immunosorbent assay (ELISA) by using the cell culture medium, with luciferase
activity serving as the control for transfection efficiency. The transfected cells were treated with warfarin at 11 different concentrations
for inhibition analysis.
In vitro analysis of the epoxide reductase activity of VKOR
and VKORL used a fluorometric-based assay (31, 40). The same
concentration of restrained and unrestrained protein was added
to a buffer containing 20 M vitamin K epoxide, 6 mM DTT,
0.1% DDM, 0.1 M NaCl, and 20 mM tris (pH 7.6). Fluorescence
of the reduced product, vitamin K hydroquinone, was detected
with excitation at 248 nm and emission at 430 nm.
For the E. coli motility assay of DsbB activity, the restrained
DsbB was transformed to a dsbB HK320 strain (32, 33). Empty
pET25b vector and pET25b-DsbB-EGFP were used as negative
and positive controls, respectively. To analyze motility associated
with each construct, a single colony was grown on a M63 minimal
plate with 0.3% agar, 0.2% glucose, 0.5 mM IPTG, and ampicillin
(100 g/ml) at 30°C for 2 days.
The DsbB activity was also assessed through a disulfide-sensitive
-galactosidase assay. The assay was carried out by transforming
the constructs into a dsbB E. coli strain with a malF-lacZ fusion
gene (HK325) (33). The transformants were streaked onto M63
minimal medium plates [X-galactosidase (100 g/ml), 0.5 mM IPTG,
1.5% agar, 0.2% glucose, 0.2% maltose, and ampicillin (100 g/ml)]
and grown at 30°C for 2 days. The maltose/maltodextrin transport system permease protein (MALF) fusion to the -galactosidase (malF-lacZ)
brings part of the protein to the E. coli periplasm and inactivates the enzyme though disulfide bond formation. Thus, the
-galactosidase is active in the dsbB strain (blue colonies) and
becomes inactive after the complementation of functional DsbB
(white colonies).
To analyze the cell junction formed by Cldn4, the restrained
and unrestrained proteins were transiently expressed in HEK293
cells. The cells were viewed under a Zeiss Airyscan FAST confocal
microscope.
To analyze the iron transport activity of restrained and unrestrained Mfrn1, the purified proteins were reconstituted into
liposomes. A dried mixture of 1-palmitoyl-2-oleoyl-glycero-3-
phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (POPE), and cardiolipin in a 55:40:5 ratio
(w/w) was resuspended (with sonication) to 10 mg/ml in 10 mM
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Protein purification
For the purification of most proteins, frozen Pichia cells were broken
by mixer mill (Retsch) and resuspended in a buffer containing
150 mM NaCl, 20 mM tris-HCl (pH 8.0), deoxyribonuclease I
(10 g/ml), and protease inhibitor cocktail. Subsequently, DDM was
added (2% final concentration) to solubilize the cell membranes for
3 hours at 4°C. After ultracentrifugation at 130,000g for 20 min, the
supernatant was incubated with TALON metal affinity resin (Clontech)
for 3 hours at 4°C. The resin was washed with 10 mM imidazole and
eluted with 250 mM imidazole in a buffer containing 150 mM NaCl,
0.2% DDM, and 20 mM tris (pH 8.0). The eluted proteins were concentrated and further purified by size exclusion chromatography
(Superdex 200 or Superose 6) in a buffer containing 150 mM NaCl,
20 mM tris (pH 8.0), 0.05% DDM, or 0.05% lauryl maltose neopentyl
glycol (LMNG); DDM was used for Tm measurement and activity
assay, and LMNG was used for crystallization.
Purification of human VKOR requires the addition of warfarin,
other vitamin K antagonists, or vitamin K epoxide before the DDM
solubilization (42). The same ligand concentration was maintained
during the entire purification process.
The purification of Mfrn1 proteins (50) has the following modifications (50). The broken cells were resuspended in 150 mM KCl,
1 mM tris(2-carboxyethyl)phosphine (TCEP), and 50 mM HepesKOH (pH 8.0). For metal affinity chromatography, the washing
(10 mM imidazole) and elution (250 mM imidazole) buffers contained
150 mM KCl, 1 mM TCEP, cardiolipin (0.05 mg/ml), 0.2% DDM,
and 20 mM Mops-KOH (pH 7.5). The buffer used for size exclusion chromatography contained 140 mM KCl, 1 mM TCEP, cardiolipin (0.05 mg/ml), 0.2% DDM, and 20 mM Mops-KOH (pH 7.5).
For functional assays, C-EGFP and N-SUMO tags were removed
from the proteins by digestion with PreScission protease (20:1, w/w)
before the size exclusion chromatography.
For the purification of DsbB proteins, E. coli cells were resuspended in 150 mM NaCl and 20 mM tris (pH 8.0) and then broken by
sonication. After centrifugation at 4700g for 15 min, the cell membranes were collected by ultracentrifugation at 130,000g for 35 min.
The membrane fraction was solubilized in a buffer containing
2% DDM, 150 mM NaCl, and 20 mM tris (pH 8.0) for 2 hours at
4°C. The membrane debris was removed by ultracentrifugation, and
the supernatant was incubated with 3 ml of TALON metal affinity
resin for 2 hours. The resin was washed with 5 mM imidazole and
eluted with 250 mM imidazole in a buffer containing 0.05% DDM,
150 mM NaCl, and 20 mM tris (pH 8.0). The proteins were further
purified through a Superdex 200 column in a buffer containing either
0.05% DDM, 150 mM NaCl, and 20 mM tris (pH 8.0) for crystallization or 0.05% DDM, 50 mM NaCl, and 20 mM Hepes (pH 7.5) for
the activity assay.

FSEC (Shimadzu) using a Superdex 200 or Superose 6 column in a
buffer containing 0.05% DDM, 150 mM NaCl, and 20 mM tris
(pH 8.0). The restrained and unrestrained proteins that had been
heated at the same temperature were loaded to FSEC consecutively
for precise Tm comparison. Fluorescence of mCherry was monitored with the excitation wavelength at 587 nm and emission at
610 nm. The peak heights were normalized to that of 4°C samples,
and the Tm was obtained by fitting the thermostability curves with
a sigmoidal dose-response equation (52).
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Crystallization and data collection
The restrained proteins were concentrated to approximately 40 mg/ml
and reconstituted into LCP by thorough mixing with monoolein
at 2:3 ratio (v/v) using a restrained syringe. With a Gryphon LCP
robot (Art Robbins), 100-nl drops of the reconstituted protein were
dispensed onto a glass plate and 800 nl of precipitant solutions was
overlaid (table S4). The LCP plates were incubated at 22°C. Crystals
generally appeared overnight and grew to an optimal size after 1 week.
The crystals were harvested from the mesophase bolus and flash-frozen
in liquid nitrogen. Diffraction data were collected with a microfocus beam and a PILATUS detector at the ID-24 beamlines of Advanced Photon Source.
Structure determination
MR was conducted with PHASER (56) using the fused sfGFP as the
search model (PDB code 2B3P) (57). This MR model was rigid body–
refined with REFMAC (58). The partial model phases were improved by solvent flattening and NCS averaging using the programs
PARROT (59) and DM (60).
For VKORL (the low-resolution data) and DsbB, cross-crystal
averaging (39) was performed between the existing model and data
of sfGFP (2B3P) and those of the sfGFP-restrained membrane
proteins using the program DMMULTI (60). Molecular masks were
generated and modified using programs NCSMASK and MAPMASK,
installed in the CCP4 suite (61), and MAPMAN and MAMA, installed in the UPPSALA software factory (62). Rotation and translation matrices that match the reference molecule to the target molecule
were calculated using program PDBSET in the CCP4 suite.
The density-modified maps were used for automatic model
building by the BUCCANEER software (59). For most datasets, the
phases after rigid body refinement of the sfGFP model and solvent
flattening with PARROT with automatically generated mask were
sufficient for the automatic building of most parts of the membrane
protein models (Table 1). The models were manually built to completeness using program COOT (63). The model refinement was by
programs installed in the PHENIX suites (64).
Liu et al., Sci. Adv. 2020; 6 : eabe3717
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Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
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